stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Gross margin
AtriCure, Inc.'s gross margin over the twelve months to 30 September 2026 was 76.7%, up 1.8 percentage points from fiscal 2025 (75.0%). Over the past ten years it has ranged from 71.6% (fiscal 2015) to 75.2% (fiscal 2023); the current reading is higher than 82% of that period. That is above the Medical Instruments & Supplies industry median of 53.6% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 75.0% | 0.29 |
| FY2024 | 74.7% | (0.54) |
| FY2023 | 75.2% | 0.79 |
| FY2022 | 74.4% | (0.60) |
| FY2021 | 75.0% | 2.75 |
| FY2020 | 72.3% | (1.51) |
| FY2019 | 73.8% | 0.83 |
| FY2018 | 73.0% | 0.76 |
| FY2017 | 72.2% | 0.58 |
| FY2016 | 71.6% | 0.05 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 77.3% | 0.04 |
| Jun 2026 | 77.2% | (0.16) |
| Mar 2026 | 77.4% | 2.42 |
| Dec 2025 | 75.0% | (0.50) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ATRC AtriCure, Inc. | 76.7% |
| NVST Envista Holdings Corporation compare | 55.9% |
| WRBY Warby Parker Inc. compare | 54.8% |
| MMED MiniMed Group, Inc. compare | 53.6% |
| XRAY DENTSPLY SIRONA Inc. compare | 50.5% |
| MMSI Merit Medical Systems, Inc. compare | 49.4% |
| ICUI ICU Medical, Inc. compare | 40.3% |
| STVN Stevanato Group S.p.A. compare | 29.1% |
| PLSE Pulse Biosciences, Inc compare | 26.8% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement